QTMeds

Drug Database Monograph

SKYRIZI 150 mg

PENDING REVIEW

Active Ingredient: RISANKIZUMAB

QTc Interval Status:

neutral

Clinical Description (Database Summary)

Scientific Sources / References

Analyse RCP (Automatique), id : 69949390

← Back to Prescription Analyzer